Concepedia

Tracey Fletcher

TF

10

Publications

601

Citations

10

H-Index

1994

Active since

Affiliations

New Frontier(Current)

Pfizer (United States)

Pfizer (Japan)

Keio University

Tokyo Medical and Dental University Hospital

Tracey Fletcher is an author at New Frontier specializing in medicine, chronic kidney disease, and vascular biology.

Top concepts

Publications per year

1994–2016

10

Publications

10

Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat.

M. Gellai, M Jugus, Tracey Fletcher et al. · Journal of Clinical Investigation · 1994 · 200 citations · Full text

, , +15

Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat

M. Gellai, Tracey Fletcher, M Pullen et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1996 · 78 citations

, , +17

Extended‐Release Once‐Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate‐Release Tofacitinib and Impact of Food

Manisha Lamba, Rong Wang, Tracey Fletcher et al. · The Journal of Clinical Pharmacology · 2016 · 73 citations · Full text

Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.

M. Gellai, M Jugus, Tracey Fletcher et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 68 citations

Contribution of Endogenous Endothelin-1 to the Maintenance of Vascular Tone: Role of Nitric Oxide

Miklos Gellai, Robin de Wolf, Tracey Fletcher et al. · Pharmacology · 1997 · 42 citations

Rows per page

1–5 of 10